Fiche publication


Date publication

avril 2023

Journal

The American journal of medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick


Tous les auteurs :
Patel S, Lam PH, Kanonidis E, Ahmed AA, Raman VK, Wu WC, Rossignol P, Arundel C, Faselis C, Kanonidis IE, Deedwania P, Allman RM, Sheikh FH, Fonarow GC, Pitt B, Ahmed A

Résumé

Renin-angiotensin system inhibitors improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF). However, less is known about their effectiveness in patients with HFrEF and advanced kidney disease.

Mots clés

Heart failure, advanced kidney disease, hospitalization, mortality, renin-angiotensin system inhibitors

Référence

Am J Med. 2023 04 3;: